Fine, N. M. (2020). Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop? JACC Case Rep.
Citação norma ChicagoFine, Nowell M. "Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?" JACC Case Rep 2020.
MLA CitationFine, Nowell M. "Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?" JACC Case Rep 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.